Clinical roundtable monograph: Emerging treatment options for TKI-resistant chronic myelogenous leukemia.

Clinical advances in hematology & oncology : H&O

Volumn 10, Issue 10 Suppl 19, 2012, Pages 1-16

  Cortes, Jorge ^a   Radich, Jerald ^b   Mauro, Michael J ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; PROTEIN KINASE INHIBITOR;

ALLOTRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; DRUG ANTAGONISM; DRUG RESISTANCE; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MORTALITY;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PROTEIN KINASE INHIBITORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84883184381     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)